• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Michael Thase: Patient Characteristics, Biomarkers That Guide Treatment for MDD

Video

The easiest to treat patients are those who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.

The easiest to treat patients are those who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.

TranscriptAre there patient characteristics or biomarkers that guide treatment protocol for patients with major depressive disorder?

The easiest to treat patients are the ones who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, and these folks have good prognoses, they have good prognostic disorders. The earlier the illness takes hold in life, the more complicating conditions you’re likely to have, the less likely you are to have acquired a family and a good job and a good insurance plan, and the things that go along with having a good prognosis.

So, these king of early onset chronicity and complexity go along with people who definitely need more intensive treatment plans—psychotherapy as well as pharmacotherapy, sometimes occupational or vocational assistance and rehabilitation. One thing Freud got right is that love and work are the kind of cornerstones to human well-being, and depression is an illness that can reduce your capacity to be sustained in love relationships and to be able to work effectively.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
ISPOR 2024 Recap
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.